An unexpected drop in consumer confidence weighed the markets down to a lower close with the Dow falling 27 points to 16,179. Nasdaq lost 5 points to 4287.
On the upside
Leerink lifted its price target on Sunesis Pharmaceuticals (Nasdaq: SNSS) from $10 to $14 and affirmed its Outperform rating.
Bloomin' Brands (Nasdaq: BLMN) impressed with sharply higher fourth quarter earnings that more than tripled to top analyst estimates.
Infinity Pharmaceuticals (Nasdaq: INFI) narrowed fourth quarter losses more than expected.
On the downside
MicroVision (Nasdaq: MVIS) extended its losses.
Amira Nature Foods (NYSE: ANFI) reported higher third quarter earnings but the results fell short of analyst expectations.
Perry Ellis (Nasdaq: PERY) warned of lower fourth quarter revenue.
In the broad market, declining issues outpaced advancers by a margin of more than 10 to 9 on the NYSE and by more than 3 to 2 on Nasdaq. The broader S&P 500 slipped 2 points to 1845. Bitcoin lost $16.86 or 3.07% to $532.05.
